Trial Profile
Efficacy of Rotigotine in controlling the drooling of Parkinson's Disease patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2018
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 13 Mar 2018 New trial record